Vitamin E (Tocopherol)Vitamin

• Where the cohorts and the trials part companyPossibly helps

  Vitamin E's proposed benefits rest on antioxidant, anti-inflammatory and platelet-inhibiting activity [1].
  
  Observational studies associate higher vitamin E intake with lower cardiovascular disease and lower dementia or Alzheimer's risk [1]. Randomized trials have not confirmed either association [4].
  
  Where the two disagree, the sections below report the trial result and say so [1]. ^[1]

• Cardiovascular diseaseNot shown to help

  The observational case was strong. A cohort of roughly 90,000 nurses linked higher vitamin E intake, mostly from supplements, to 30–40% lower coronary heart disease incidence [1].
  
  Four randomized trials then found nothing: HOPE, HOPE-TOO, the Women's Health Study and Physicians' Health Study II reported no reduction in cardiovascular events, heart attacks or cardiovascular death [1].
  
  Physicians' Health Study II found the opposite of a benefit. Men taking 400 IU every other day for 8 years had a significantly increased risk of hemorrhagic stroke [1]. ^[1]

• Prostate cancer risk — a documented increaseNot shown to help

  The cancer evidence for vitamin E is largely negative, and in one place actively unfavourable [1].
  
  The large SELECT trial gave 400 IU/day of synthetic vitamin E for about 5.5 years, with a further 1.5 years of follow-up [1].
  
  Men in that arm had a statistically significant 17% higher risk of prostate cancer than men on placebo [1]. ^[1]

• Macular degeneration — the formula, not the vitaminPossibly helps

  These two findings get conflated constantly, and they are not the same claim [1].
  
  In AREDS, a high-dose antioxidant formula cut the 5-year risk of progression to advanced AMD by 25% in people already at high risk [1].
  
  That formula contained 400 IU (180 mg) vitamin E plus beta-carotene, vitamin C, zinc and copper [1].
  
  AREDS2 confirmed a benefit for similar formulations [1].
  
  Vitamin E on its own, without the other antioxidants and minerals, has not been shown to lower AMD or cataract risk in randomized trials [1]. ^[1]

• Alzheimer's disease and cognitive declinePossibly helps

  One trial of 341 patients with moderate Alzheimer's disease found 2,000 IU/day delayed functional deterioration and the need for institutionalization over 2 years, against placebo [1].
  
  Participants in that arm also had significantly more falls [1].
  
  Trials in healthy older adults, and in those with mild cognitive impairment, found no benefit [1]. Most current evidence does not support vitamin E for cognitive decline in healthy ageing [1]. ^[1]

• Fatty liver disease (NASH/MASH)Possibly helps

  In the PIVENS trial, 800 IU/day (536 mg/day) of natural RRR-alpha-tocopherol significantly improved liver-biopsy markers of NASH over 96 weeks, against placebo, in non-diabetic adults [4].
  
  In children with fatty liver disease, the TONIC trial used the same dose [4]. It improved a disease-activity score but did not significantly lower liver enzymes against placebo [4].
  
  These liver findings are read as preliminary. They are not an established clinical recommendation [4]. ^[4]

• Frank deficiency is rare, and has not been observed in people who simply eat little vitamin E [1].
• It occurs almost only alongside fat-malabsorption disorders — Crohn's disease, cystic fibrosis, chronic cholestatic liver disease [1].
• The reason is mechanical: absorbing vitamin E from the digestive tract requires dietary fat [1].
• It also occurs in rare inherited conditions, notably abetalipoproteinemia and ataxia with vitamin E deficiency (AVED) [1].
• In AVED the liver's alpha-tocopherol transfer protein is defective or absent, so circulating alpha-tocopherol never gets replenished [1].
• Peripheral neuropathy — nerve damage causing loss of feeling and loss of reflexes in the arms and legs [1].
• Ataxia, meaning loss of control over body movements [1].
• Skeletal myopathy, meaning muscle weakness [1].
• Retinopathy, meaning vision problems [1].
• Impairment of the immune response [1].
• In AVED the nerve damage is progressive and ends in loss of the ability to walk, unless large supplemental doses are given [1].
• Premature infants below 1,500 g birth weight may also be deficient [1].
• Supplementing that group may lower the risk of certain retinal complications, but can also raise infection risk [1].^[1]

• Alpha-tocopherolEvery RDA, UL and Daily Value figure on this page is expressed as alpha-tocopherol .

  Elemental content

  The only one of the eight forms that meets human vitamin E requirements [1].

  Absorption

  The liver's alpha-TTP has essentially 100% affinity for it, against about 38% for beta-, 9% for gamma- and 2% for delta-tocopherol [5].

  Best for

  Every RDA, UL and Daily Value figure on this page is expressed as alpha-tocopherol [1].

• Natural (d-alpha-tocopherol)Fewer milligrams for the same RDA credit — 1 mg natural counts as 2 mg synthetic .

  Elemental content

  RRR-alpha-tocopherol, a single stereoisomer [1].

  Absorption

  Roughly twice as potent by weight as the synthetic form. 1 mg equals 1.49 IU [1].

  Best for

  Fewer milligrams for the same RDA credit — 1 mg natural counts as 2 mg synthetic [1].

• Synthetic (dl-alpha-tocopherol)Cheaper. It is also the form used in SELECT, the trial that found raised prostate cancer risk .

  Elemental content

  All-rac-alpha-tocopherol, a mixture of eight stereoisomers, only some of which the body retains [1].

  Absorption

  About half the biological potency by weight. 1 mg equals 2.22 IU [1].

  Best for

  Cheaper. It is also the form used in SELECT, the trial that found raised prostate cancer risk [1].

• Gamma-tocopherolResearchers note activities alpha-tocopherol lacks, such as scavenging reactive nitrogen species .

  Elemental content

  The dominant vitamin E form in the American diet, from soybean, canola and corn oil [1].

  Absorption

  Poorly retained by alpha-TTP at about 9% affinity, so it never accumulates the way alpha-tocopherol does [5].

  Best for

  Researchers note activities alpha-tocopherol lacks, such as scavenging reactive nitrogen species [5]. Much less studied.

• TocotrienolsStudied for distinct antioxidant, anti-inflammatory and membrane-penetration properties .

  Elemental content

  Most abundant in palm oil, up to 70% of its vitamin E content, and in annatto [6].

  Absorption

  Lower oral bioavailability than tocopherols, from weak alpha-TTP binding plus faster clearance by the liver [6].

  Best for

  Studied for distinct antioxidant, anti-inflammatory and membrane-penetration properties [6]. Not a substitute for alpha-tocopherol in RDA terms [1].

• Mixed tocopherolsA reasonable idea on an unsettled premise .

  Elemental content

  Blends of non-alpha forms, sometimes with tocotrienols, aiming to mimic the mix found in food [2].

  Absorption

  NIH ODS says scientists do not yet know whether those other forms beat alpha-tocopherol alone in a supplement [2].

  Best for

  A reasonable idea on an unsettled premise [2].

• Acetate and succinate estersNo practical downside. The ester is a shelf-life decision rather than an absorption one .

  Elemental content

  Supplemental alpha-tocopherol esterified for shelf stability [1].

  Absorption

  The body hydrolyzes and absorbs these esters about as efficiently as unesterified alpha-tocopherol [1].

  Best for

  No practical downside. The ester is a shelf-life decision rather than an absorption one [1].

• Hemorrhagic stroke in two trials

  Two clinical trials found increased hemorrhagic stroke risk among people taking supplemental alpha-tocopherol [1].
  
  Finnish male smokers took 50 mg/day for about 6 years. US male physicians took 400 IU every other day for 8 years [1].
  
  The lower of those two doses sits well under the 1,000 mg/day UL [1]. ^[1]

• All-cause mortality — the meta-analyses disagree

  Two meta-analyses linked vitamin E supplementation, including at doses below the UL, to small but statistically significant increases in all-cause mortality [1].
  
  In one, risk began rising around 150 IU/day and was clearly increased at 400 IU/day [1].
  
  A review restricted to healthy people taking vitamin E for primary disease prevention found no convincing evidence of increased mortality [1].
  
  Those pooled analyses drew mostly on trials of sick or elderly participants. The practical implications remain debated, and we are not resolving that here [1]. ^[1]

• Bleeding signs that need medical attention

  Cleveland Clinic's monograph for vitamin E capsules lists bloody or black tarry stools, vomiting blood or coffee-ground material, and red or dark brown urine [10].
  
  Small red or purple skin spots, and unusual bruising or bleeding, belong on the same list [10].
  
  Milder reported effects are diarrhea, fatigue, headache and nausea [10]. ^[10]

• Contact dermatitis from topical vitamin E

  This one is about skin products, not capsules — true dietary allergy to ingested vitamin E is uncommon [7].
  
  A PubMed literature review counted about 931 reported cases of vitamin-E-induced contact dermatitis, most of them from a single large study, with no deaths and three hospitalizations [7].
  
  A separate review calls vitamin E contact allergy a controversial subject, noting confirmed sensitization in only a minority of suspected cases [8]. ^[7]

• During chemotherapy or radiotherapy

  Oncologists generally advise against antioxidant supplements, vitamin E included, during chemotherapy or radiotherapy [1].
  
  The reasoning is that an antioxidant could theoretically shield cancer cells from the oxidative damage those therapies rely on [1].
  
  A systematic review of randomized trials has called that concern into question, and further research is needed [1]. ^[1]

• High doses in pregnancy

  A prospective study followed 82 women taking 400–1,200 IU/day through the first trimester [11].
  
  It found no increase in major birth defects, live births, preterm delivery or miscarriage, but a statistically significant lower mean birth weight — 3,173 g against 3,417 g in controls [11].
  
  A Cochrane review of over 21,000 women found supplementation, usually with vitamin C, did not reduce stillbirth, preterm birth, pre-eclampsia or poor fetal growth [13].
  
  It was associated with increased prelabor rupture of membranes at term and self-reported abdominal pain, so routine supplementation above the RDA is not recommended [13]. ^[11]

• Anticoagulants and antiplatelet drugs

  This is the interaction that matters most. Vitamin E inhibits platelet aggregation and antagonizes vitamin-K-dependent clotting factors [1].
  
  Large supplemental doses, probably above 400 IU/day, taken with warfarin or similar anticoagulant and antiplatelet drugs can increase bleeding risk [1].
  
  The risk is greater when vitamin K intake is low [1]. ^[1]

• Simvastatin plus niacin

  In one trial, vitamin E combined with vitamin C, selenium and beta-carotene blunted a rise in HDL2 cholesterol [1].
  
  That rise had been produced by a simvastatin-plus-niacin regimen, and HDL2 is the fraction the regimen was aiming at [1]. ^[1]

• Cholestyramine, mineral oil and orlistat

  Cleveland Clinic's drug monograph for vitamin E capsules and tablets lists all three as potential interactions [10].
  
  Each reduces absorption of fat-soluble nutrients, vitamin E among them [10]. ^[10]

Vegetable oils, nuts and seeds are the richest sources, with green leafy vegetables and fortified cereals adding meaningful amounts [1].

Wheat germ oil is in a class of its own at 20.3 mg per tablespoon, which is 135% of the Daily Value [1].

Then the nuts and seeds: dry-roasted sunflower seeds 7.4 mg/oz (49% DV), dry-roasted almonds 6.8 mg/oz (45% DV), hazelnuts 4.3 mg/oz (29% DV) and peanuts 2.2 mg/oz (15% DV) [1].

Among oils, sunflower gives 5.6 mg per tablespoon (37% DV), safflower 4.6 mg (31% DV), corn 1.9 mg (13% DV) and soybean 1.1 mg (7% DV) [1].

Vegetables contribute less: boiled spinach 1.9 mg per half cup, boiled broccoli 1.2 mg and raw spinach 0.6 mg per cup [1].

Fruit less again: one kiwifruit 1.1 mg, half a cup of mango 0.7 mg and a medium tomato 0.7 mg [1].

Two tablespoons of peanut butter supply 2.9 mg (19% DV) [1]. The FDA Daily Value is 15 mg for adults and children 4 and up [1].

Despite all that, national US dietary surveys repeatedly find most people taking in less than the RDA, partly because fat added during cooking is often left out of intake estimates [1].

There is a form problem too. Most dietary vitamin E in the American diet is gamma-tocopherol from soybean, canola and corn oil, not the alpha-tocopherol in nuts, seeds and specialty oils [1].

Cooking cuts both ways, and the studies genuinely disagree [14]. Heat can break down cell walls and inactivate oxidizing enzymes, raising measurable tocopherol in vegetables like broccoli and spinach; other studies report losses instead [14].

Frying a vitamin-E-poor vegetable in a vitamin-E-rich oil raises the food's content through oil absorption [14].

Storage time, moisture and oxygen exposure are the main drivers of loss in oils, nuts and whole grains [14].

Vitamin E needs dietary fat to be absorbed, so take it with a meal or snack rather than on an empty stomach [3].

A Cleveland Clinic physician notes that even a small amount of low-fat or whole milk, yogurt, or food cooked in oil is enough to help [3].

Cleveland Clinic's own drug information for vitamin E capsules says much the same. It may work best taken with food, at regular intervals [10].

No government or clinical source reviewed here named morning or evening as better for vitamin E [3]. The consistent guidance is about the meal, not the clock.